A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...

Early adopters of GLP-1 drugs have now lost the weight and are beginning to transition off them. How can F&B support the ...

GLP-1 RA use is associated with better graft and patient survival among kidney transplant recipients with diabetes.

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily ...

Gasherbrum Bio Inc. has described glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of type 2 diabetes, dyslipidemia, schizophrenia, hypertension, obesity, ...

We recently published a list of Was Jim Cramer Right About These 13 Stocks? In this article, we are going to take a look at ...

OPKO Health and Entera Bio, a developer of oral peptides and protein replacement therapies, entered into a license agreement ...

Gastroparesis is a chronic gastrointestinal condition that happens when the stomach can’t empty well, causing delayed ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

“Whether consumers are using GLP-1 medications for weight management or are reducing sugar intake as part of their overall ...